The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVenture Life Regulatory News (VLG)

Share Price Information for Venture Life (VLG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 40.75
Bid: 40.00
Ask: 41.50
Change: 0.25 (0.62%)
Spread: 1.50 (3.75%)
Open: 40.20
High: 40.75
Low: 40.20
Prev. Close: 40.50
VLG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of Options

6 Jan 2020 15:38

RNS Number : 8950Y
Venture Life Group PLC
06 January 2020
 

6 January 2020

 

Venture Life Group plc

("Venture Life" or the "Company")

Grant of Options

Venture Life (AIM: VLG), the international consumer self-care group focused on developing, manufacturing and commercialising products for the self-care market, announces that it has granted further share options ("Options") over ordinary shares of 0.3 pence each in the capital of the Company ("Ordinary Shares").

On 6 January 2020 (the "Date of Grant"), Venture Life granted Options over a total of 4,000,000 Ordinary Shares to its four Executive Directors at a strike price of 33.7 pence per share, being the average of the closing market price on the five business days starting 19 December 2019. Vesting of the Options is subject to continued employment. The Options will vest in equal tranches on the following dates: 31 March 2020, 31 March 2021 and 31 March 2022.

Director

Position

Number of Options in this grant

Jerry Randall

Chief Executive Officer

 1,000,000

Gianluca Braguti

Chief Manufacturing Officer

 1,000,000

Sharon Collins

Chief Commercial Officer

 1,000,000

Andrew Waters

Chief Financial Officer

 1,000,000

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail. 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.)

Names

1. Jerry Randall

2. Gianluca Braguti

3. Sharon Collins

4. Andrew Waters

2.

Reason for the notification

a.)

Position/status

1. Chief Executive Officer

2. Chief Manufacturing Officer

3. Chief Commercial Officer

4. Chief Financial Officer

b.)

Initial notification /Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.)

Name

Venture Life Group PLC

b.)

LEI

213800S8CZUPLAB2KC70

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.)

Description of the financial instrument, type of instrument

Options over Ordinary Shares of 0.3 pence each in Venture Life Group plc

b.)

Identification code

GB00BFPM8908

c.)

Nature of the transaction

Grant of Options over Ordinary Shares

d.)

Price and volumes

 

Price

Volume

1. 33.7 pence

2. 33.7 pence

3. 33.7 pence

4. 33.7 pence

1. 1,000,000

2. 1,000,000

3. 1,000,000

4. 1,000,000

 

 

e.)

Aggregated information

- Aggregated volume

- Price

 

n/a

f.)

Date of the transaction

6 January 2020

g.)

Place of the transaction

Outside a trading venue

 

For further information please contact: 

Venture Life Group PLC

+44 (0) 1344 578 004

Jerry Randall, Chief Executive Officer

Andrew Waters, Chief Financial Officer

 

Cenkos (Nominated Adviser and Joint Broker)

+44 (0) 207 397 8900

Mark Connelly / Stephen Keys / Cameron MacRitchie (Corporate Finance) / Russell Kerr / Michael Johnson (Sales)

Alma PR

venturelife@almapr.com or +44 (0) 203 405 0208

Helena Bogle/Hilary Buchanan/Jessica Joynson

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHFLFVELRIRIII
Date   Source Headline
24th Nov 20177:00 amRNSNew exclusive partner secured in Austrian market
23rd Nov 201711:14 amRNSUK Bond Network presentation
14th Nov 20177:00 amRNSVox Markets
30th Oct 20177:00 amRNSUltraDEX update
10th Oct 20177:00 amRNSHolding(s) in Company
2nd Oct 20177:00 amRNSFDA approval for the US market
21st Sep 20177:00 amRNSHalf-year Report
7th Sep 20177:00 amRNSDistribution partners and Lubatti China update
4th Sep 20177:00 amRNSNotice of Results
7th Aug 20174:24 pmRNSDirector/PDMR Shareholding
19th Jul 20177:00 amRNSDistribution partner for UltraDEX & patent update
12th Jul 20177:00 amRNSTrading update
23rd May 201710:59 amRNSResult of AGM
23rd May 20177:00 amRNSUltraDEX Patent Grants and Distribution Update
18th May 20177:00 amRNSTwo new CE Mark approvals
10th May 20179:00 amRNS'1000 Companies to Inspire Britain' 2017 report
4th May 20177:00 amRNSChange of Adviser
4th May 20177:00 amRNSGrant of Options
25th Apr 20177:00 amRNS2017 Long Term Incentive Plan and Grant of Options
29th Mar 20173:36 pmRNSUK Investor Show attendance
23rd Mar 20177:00 amRNSFinal Results
1st Mar 20177:00 amRNSDirectorate Change
1st Feb 20171:08 pmRNSHolding(s) in Company
31st Jan 20174:39 pmRNSInvestor Day presentation now available
26th Jan 20177:00 amRNSTrading update
20th Dec 20167:00 amRNSInvestor evening
29th Nov 20166:06 pmRNSHolding(s) in Company
28th Nov 20167:00 amRNSAppointment of Vox Markets
17th Nov 20167:00 amRNSInvestor evening
14th Nov 20167:00 amRNSTrading update
10th Nov 20167:00 amRNSDirectorate Change
10th Oct 20167:00 amRNSUltraDEX advertising launch
7th Oct 201612:10 pmRNSIssue of Equity
29th Sep 20167:00 amRNS2016 LTIP adopted & Grant of Options
21st Sep 20167:00 amRNSHalf-year Report
21st Sep 20167:00 amRNSAppointment of joint broker
7th Sep 20167:00 amRNSNotice of Results
29th Jul 20167:00 amRNSPre-close trading statement
22nd Jun 201612:35 pmRNSResult of AGM
14th Jun 201612:18 pmRNSDirector/PDMR Shareholding
17th May 20164:17 pmRNSDirector/PDMR Shareholding
9th May 20161:13 pmRNSDirector/PDMR Shareholding
9th May 20167:00 amRNSAnnual Financial Report
4th May 20167:00 amRNSFinal Results
3rd May 20167:00 amRNSFirst distribution agreements signed for UltraDEX
31st Mar 20167:00 amRNSDistribution Deals on Benecol 'once a day' Sachet
29th Mar 20167:02 amRNSNotice of Results
18th Mar 201611:04 amRNS'1000 Companies to Inspire Britain 2016' report
7th Mar 20167:00 amRNSCompletion of Acquisition
3rd Mar 20167:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.